Ribosomal protein L9 is a potential therapeutic target for B-ALL through the activation of the p53 signaling pathway

Ribosomal protein L9 is a potential therapeutic target for B-ALL through the activation of the p53 signaling pathway

B-cell acute lymphocytic leukemia (B-ALL) is a malignant hematological disorder marked by the aberrant proliferation of abnormal B lymphocytes. Although recent advancements have highlighted the pivotal role of ribosomes in the progression of B-ALL, the specific function of ribosomal protein L9 (RPL9...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinxin Li, Wenting Meng, Xi Wang, Siyong Huang, Jianbin Wang, Han Liang, Dailing Si
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Immunology
Subjects:
B-ALL
RPL9
cell proliferation
apoptosis
p53 signaling pathway
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1560706/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items